Young, Jonathan R.
Yanagihara, Adare
Dew, Rachel
Kollins, Scott H. http://orcid.org/0000-0001-6847-6935
Article History
Accepted: 10 March 2021
First Online: 26 March 2021
Declarations
:
: JRY, AY, and RD have nothing to disclose. SHK has received research support and/or consulting fees from the following sources in the past 24 months: Akili Interactive, Arbor Pharmaceuticals, BehaVR, Bose, Ironshore Pharma, KemPharm, Neos, OnDosis, Otsuka, Rhodes, Sana Health, Tali Health, Tris Pharma. SHK has received equity from Akili Interactive and holds equity and is a co-founder of Behavioral Innovations Group.
: Dr. Young is supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Veterans Affairs Durham Health Care System, and the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC). There are no other funding sources relevant to this work.
: All authors were involved in the review paper concept and design, acquisition of data, or analysis and interpretation of data; drafting/revising the manuscript for important intellectual content; and approval of the final version to be published.
: There are no source data for this paper and the approach for identifying and reviewing articles is described in the article.
: Not relevant.
: Not relevant.
: Not relevant.
: Not relevant.